Center for Biologic Policy Evaluation

Further the common good and general welfare of all by researching, analyzing and evaluating the regulatory standards used in approving biologics and biosimilars across the globe and by educating the public on those regulatory standards. Organized, compiled and analyzed data in 12 countries as it relates to the approval of biologics & biosimilars. Organized the resulting data and developed a website to reflect the regulatory schemes of the 12 countries. The organization engaged in no significant program activity during the tax year.